Efficacy of Acceptance and Commitment Therapy for the Management of Quality of Life in Patients Post Myocardial Infarction
NCT ID: NCT06548282
Last Updated: 2025-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2024-06-21
2024-09-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acceptance and Commitment Therapy for Patients With Chronic Heart Failure and Their Caregivers on Their Quality of Life
NCT04917159
Effects of Nurse-led Case Management Based on Prevention and Control of Acute Myocardial Infarction
NCT05384028
MOTIVATional intErviewing to Improve Self-care in Heart Failure Patients
NCT02894502
Efficacy of CBT on Positive Health Outcomes of Chronic Heart Failure Patients With Depression
NCT04949945
Effect of Behavioral Management on Quality of Life in Heart Failure
NCT00012870
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental
Who receives intervention i.e. Acceptance and Commitment Therapy
Acceptance and commitment therapy
Introduction: Build rapport and complete pre-assessment questionnaires.
First Session:
Introduce therapist, ACT principles, and MI complications. Provide psychoeducation and assign homework.
Second Session:
Review feedback and encourage change. Assign homework.
Third Session:
Discuss acceptance and coping strategies. Assign homework.
Fourth Session:
Discuss cognitive diffusion and unhelpful thoughts. Assign homework.
Fifth Session:
Explore self-concept and mindfulness. Assign homework.
Sixth Session:
Identify and elaborate on values. Assign homework.
Seventh Session:
Discuss values, goals, and barriers. Assign homework.
Eighth Session:
Discuss commitment to action and relapse prevention. Administer post-test and express gratitude.
Waitlist Control
Who would receive intervention after study completion
Acceptance and commitment therapy
Introduction: Build rapport and complete pre-assessment questionnaires.
First Session:
Introduce therapist, ACT principles, and MI complications. Provide psychoeducation and assign homework.
Second Session:
Review feedback and encourage change. Assign homework.
Third Session:
Discuss acceptance and coping strategies. Assign homework.
Fourth Session:
Discuss cognitive diffusion and unhelpful thoughts. Assign homework.
Fifth Session:
Explore self-concept and mindfulness. Assign homework.
Sixth Session:
Identify and elaborate on values. Assign homework.
Seventh Session:
Discuss values, goals, and barriers. Assign homework.
Eighth Session:
Discuss commitment to action and relapse prevention. Administer post-test and express gratitude.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acceptance and commitment therapy
Introduction: Build rapport and complete pre-assessment questionnaires.
First Session:
Introduce therapist, ACT principles, and MI complications. Provide psychoeducation and assign homework.
Second Session:
Review feedback and encourage change. Assign homework.
Third Session:
Discuss acceptance and coping strategies. Assign homework.
Fourth Session:
Discuss cognitive diffusion and unhelpful thoughts. Assign homework.
Fifth Session:
Explore self-concept and mindfulness. Assign homework.
Sixth Session:
Identify and elaborate on values. Assign homework.
Seventh Session:
Discuss values, goals, and barriers. Assign homework.
Eighth Session:
Discuss commitment to action and relapse prevention. Administer post-test and express gratitude.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients attending follow-up visits at the hospital.
3. Patients experiencing distress.
4. Patients exhibiting features of Type D personality.
5. Patients reporting low levels of:
* Quality of Life (QoL)
* Medication adherence
* Social support
* Acceptance
* Psychological flexibility
6. Patients aged 18 years and above.
7. Both genders.
8. Patients who can understand Urdu.
9. Patients who can provide informed consent.
Exclusion Criteria
2. Patients with myocardial infarction (MI) and other chronic co-morbid diseases, such as:
* Cancer
* Cognitive deficits
* Chronic psychological disorders
3. Patients with silent myocardial infarction.
4. Patients younger than 18 years.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fatima Jinnah Women University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sehrish Khan
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sehrish Khan, PhD Scholar
Role: PRINCIPAL_INVESTIGATOR
Fatima Jinnah women University, Rawalpindi, Pakistan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Armed Forces Institute of Cardiology
Rawalpindi, Punjab Province, Pakistan
Rawalpindi Institute of Cardiology
Rawalpindi, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FJWU/EC/2024/88
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.